Glutathione peroxidase 3 is a selenium-containing enzyme primarily synthesized in renal proximal tubular cells and secreted into plasma, where it catalyzes the reduction of hydrogen peroxide and organic hydroperoxides using glutathione as a substrate[1][2][5][6][7]. It is distinguished from other glutathione peroxidases by its extracellular location and tetrameric structure, and it plays a key role in protecting the extracellular environment and various tissues from ROS-induced oxidative stress, supporting cellular health and defending against inflammation and degenerative processes, with clear implications for human disease[1][5][7].
Drugs or interventions that increase GPX3 activity (such as selenium or antioxidant therapies) act by boosting its enzymatic reduction of hydrogen peroxide and other peroxides, thereby reducing oxidative tissue injury.
03
Biological functions
Antioxidant defenseDetoxification of peroxidesRegulation of reactive oxygen species (ROS)Maintenance of redox balanceProtective role in inflammation
04
Disease associations
Cancer (shown to modulate tumor growth and oxidative stress responses)Cardiovascular disease (implicated in protecting against atherosclerosis and vascular damage)Inflammatory diseases (plays a role in mitigating inflammation-associated oxidative stress)Neurodegenerative disease (possible, due to involvement in oxidative stress, though not as well described as other GPX family members)
05
Safety considerations
Selenium oversupplementation can lead to toxicity due to excessive GPX activity.Inhibition or deficiency of GPX3 increases oxidative stress, raising risk for tissue damage and disease progression.Lack of tissue specificity with systemic targeting.
06
Interacting drugs
No small-molecule drugs directly targeting GPX3 are currently available clinically. GPX3 activity is responsive to selenium supplementation and modulated by redox-active drugs or compounds (e.g., N-acetylcysteine), but these are not selective GPX3 inhibitors or activators.
07
Biomarkers
GPX3 plasma level is used as a biomarker of systemic antioxidant capacity and the body's selenium statusChanges in GPX3 expression or enzymatic activity are found in cancer, cardiovascular disease, and inflammatory conditions, making it a prognostic and diagnostic marker
Beyond the preview
Go deeper on Glutathione peroxidase 3 (GPX3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutathione peroxidase 3 (GPX3).